Vaccinology webinars

These pages provides access to the recording of various vaccinology webinars

The power and limitations of immunobridging studies: the example of COVID-19 vaccines

Details

Discussion topic:
The power and limitations of immunobridging studies: the example of COVID-19 vaccines
 

Presentations :

Bridging studies – why and how?
Peter Dull, Bill & Melinda Gates Foundation

Criteria and requirement for the licensing of new vaccines with special emphasis on COVID-19
the view of EMA. Marco Cavaleri, Head of Office Biological Health Threats and Vaccine Strategy, European Medicines Agency.

Chair: Hanna Nohynek,
Finnish Institute for Health and Welfare, Finland and Member of the ADVAC Scientific Committee